Sit Investment Associates’s Cutwater Select Income Fund CSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-427,373
Closed -$8.66M 525
2016
Q3
$8.66M Buy
427,373
+9,365
+2% +$190K 0.23% 128
2016
Q2
$8.29M Buy
418,008
+534
+0.1% +$10.3K 0.22% 128
2016
Q1
$7.99M Buy
417,474
+5,922
+1% +$110K 0.15% 131
2015
Q4
$7.51M Buy
411,552
+213,661
+108% +$4.03M 0.14% 139
2015
Q3
$3.78M Sell
197,891
-28,575
-13% -$538K 0.07% 188
2015
Q2
$4.16M Sell
226,466
-18,301
-7% -$354K 0.08% 175
2015
Q1
$4.9M Sell
244,767
-26,480
-10% -$519K 0.08% 165
2014
Q4
$5.25M Buy
271,247
+12,464
+5% +$244K 0.09% 183
2014
Q3
$5.11M Sell
258,783
-11,469
-4% -$225K 0.09% 183
2014
Q2
$5.44M Sell
270,252
-3,999
-1% -$78.3K 0.09% 199
2014
Q1
$5.33M Buy
274,251
+65,740
+32% +$1.23M 0.09% 192
2013
Q4
$3.82M Sell
208,511
-4,944
-2% -$88.5K 0.07% 217
2013
Q3
$3.8M Sell
213,455
-67,556
-24% -$1.2M 0.07% 208
2013
Q2
$5.16M Buy
+281,011
New +$5.56M 0.1% 173

Other funds holding CSI

Sit Investment Associates's CSI Position: Q4 2016 in Review

Sit Investment Associates sold out of Cutwater Select Income Fund (CSI) in Q4 2016, closing a stake of 427,373 shares — an estimated $8.66M sold.

Sit Investment Associates first reported a position in CSI in Q2 2013 and held it in 14 quarters. The position peaked at $8.66M in Q3 2016. 1 fund tracked by Wall St. Rank holds CSI as of Q4 2016.

  • Sit Investment Associates reported no remaining Cutwater Select Income Fund position as of Q4 2016 after selling out during the quarter.
  • Sit Investment Associates sold 427,373 Cutwater Select Income Fund shares in Q4 2016, an estimated $8.66M.
  • Sit Investment Associates first reported a position in Cutwater Select Income Fund in Q2 2013 and held it in 14 quarters.
  • Sit Investment Associates's Cutwater Select Income Fund position peaked at $8.66M in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Cutwater Select Income Fund as of Q4 2016.

Based on Sit Investment Associates's 13F filing for Q4 2016, filed 19 Jan 2017.